<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02333500</url>
  </required_header>
  <id_info>
    <org_study_id>14-AOI-06</org_study_id>
    <nct_id>NCT02333500</nct_id>
  </id_info>
  <brief_title>Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa</brief_title>
  <official_title>Pilot Study: a Comparative Study Between Serum Levels of Oxytocin and Incitement to Use Olfactory Stimuli in Restrictive Anorexia Nervosa in Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Lenval</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Lenval</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective pilot study will compare adolescents with restrictive anorexia nervosa who
      participated for 3 months at olfactory workshops, patients who did not, and healthy
      patients.The groups will be evaluated before the workshops and after three months, with the
      wanting score after olfactory stimuli and with serum oxytocin level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The restrictive anorexia nervosa (AN) in adolescents is an eating disorder with decreased
      desire to eat (wanting) following olfactory stimulation. Oxytocin is an hormone involved in
      the neuromodulation of eating behavior, but also involved in olfactory perception in
      schizophrenia patients, and in social cognition in patients with autism. Its plasma level was
      found low in anorexic patients compared to control subjects.

      Because of the similarity in disorders of social cognition between these three diseases, we
      assume that the desire to eat evoked by olfactory perception varies with the plasma oxytocin
      levels.

      With a prospective pilot study we will compare patients with AN who participated for 3 months
      at olfactory workshops, AN patients who did not, and healthy patients.

      The groups will be evaluated before the workshops and after three months, with the wanting
      score after olfactory stimuli and with serum oxytocin level.

      One application of this study will be the use of ocytocyne nasal spray to increase the eating
      desire and to allow weight regain
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score &quot;Wanting&quot; to olfactory stimuli</measure>
    <time_frame>at 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oxytocin serum level</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores to clinical scales</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores to hedonicity scale</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scores to &quot;liking&quot;-&quot;wanting&quot; tests</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anorexia</condition>
  <arm_group>
    <arm_group_label>olfactory workshop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Influence of sensory therapy on the rate of oxytocin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>other workshop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Influence of other workshop on the rate of oxytocin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Rate of oxytocin of the control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>olfactory workshop</intervention_name>
    <description>olfactory workshop</description>
    <arm_group_label>olfactory workshop</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>other workshop</intervention_name>
    <description>other workshop: discussion group, dance and body Expression</description>
    <arm_group_label>other workshop</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>control group</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medical-Review

          -  Female or male -Sexe,

          -  11 to 18 years

          -  Anorexia nervosa diagnosed according to the criteria DSM V

          -  Outpatient care or hospitalization

          -  Be able to answer the clinicals evaluations questionnaires

          -  Affiliated to social security

          -  Consentement of the legal representative and the patient

        Exclusion Criteria:

          -  Somatic comorbidity associated with diabetes, celiac disease, brain tumor

          -  Intolerance odors, predisposed to develop asthma and / or respiratory allergies
             Pathologie chronic rhino-sinus

          -  Hyposmiques or anosmic

          -  Patients not of an inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florence ASKENAZY, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux pediatriques CHU de Nice Fondation Lenval</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanina OLIVERI, CRA</last_name>
    <phone>0033 4 92 03 42 54</phone>
    <email>oliveri.v@chu-nice.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fanny Maria, neuropsy</last_name>
    <email>fannymaria@hotmail.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation Lenval Hôpitaux pediatriques CHU de Nice Fondation Lenval</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence ASKENAZY, PU-PH</last_name>
      <email>askenasy.f@chu-nice.fr</email>
    </contact>
    <contact_backup>
      <last_name>Fanny Maria, neuropsy</last_name>
      <email>fannymaria@hotmail.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2014</study_first_submitted>
  <study_first_submitted_qc>January 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2015</study_first_posted>
  <last_update_submitted>September 30, 2015</last_update_submitted>
  <last_update_submitted_qc>September 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

